logo

For the Inventor, By the Inventor

Wokingham, United Kingdom

Jonathan Richard Anthony Roffey

This inventor holds 14 USPTO granted patents. Top assignees: Vernalis Research Limited, Hoffmann-La Roche Inc.. Active years: 2002-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Richard Anthony Roffey. Retrieved from https://idiyas.com/inventor/jonathan-richard-anthony-roffey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 7.1

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 49(Granted Patents)


Location History:

  • Winnersh, GB (2002)
  • Wokingham, GB (2002 - 2008)

Company Filing History:

goldMedal14 out of 43 
 
Vernalis Research Limited
 patents
silverMedal2 out of 5,024 
 
Hoffmann-La Roche Inc.
 patents
where one patent can have more than one assignee

Years Active: 2002-2008

Loading Chart...
14 patents (USPTO):Explore Patents
1. 7323487 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2008-01-29),
2. 7323486 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2008-01-29),
3. 7323473 - [object Object] (2008-01-29),
4. 7173056 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2007-02-06),
5. 7166632 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2007-01-23),
6. 7166613 - [object Object] (2007-01-23),
7. 7098337 - 1,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivatives (2006-08-29),
8. 7022707 - Piperazine derivatives (2006-04-04),
9. 6962939 - [object Object] (2005-11-08),
10. 6706750 - Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal application (2004-03-16),
11. 6552062 - Indazole derivatives with 5-HT2 receptor activity (2003-04-22),
12. 6433175 - Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists (2002-08-13),
13. 6380238 - Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands (2002-04-30),
14. 6365598 - Pyrroloquinolines for treatment of obesity (2002-04-02),

Title: The Innovative Contributions of Jonathan Richard Anthony Roffey

Introduction

Jonathan Richard Anthony Roffey is a notable inventor based in Wokingham, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work primarily focuses on chemical compounds and their therapeutic applications.

Latest Patents

Roffey's latest patents include a chemical compound of formula (I) that is designed for use in therapy, particularly as an agonist or antagonist of a 5HT receptor. This compound has potential applications in treating various disorders of the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, sleep apnea, and obesity. Another notable patent involves condensed indoline derivatives that serve as 5HT2C receptor ligands, further emphasizing his focus on innovative therapeutic solutions.

Career Highlights

Throughout his career, Roffey has worked with prominent companies such as Vernalis Research Limited and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research.

Collaborations

Roffey has collaborated with esteemed colleagues, including David Reginald Adams and Howard Langham Mansell. These partnerships have played a crucial role in enhancing his research and development efforts.

Conclusion

Jonathan Richard Anthony Roffey's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his significant impact on medical research and therapy development. His work continues to pave the way for advancements in treating various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…